Efficacy and Cost Effectiveness of Relaxation and Response to CHF
Completed · Not applicable
Conditions studied: Chronic Heart Failure
In brief
Despite the development of significant pharmaceutical treatments, morbidity and mortality of chronic heart failure (CHF) patients remain high, patients� quality of life is poor, and their health care utilization is heavy. It is therefore important to find a cost effective non-pharmaceutical treatment to help CHF patients manage the disease. The relaxation response has been found to be effective in managing CHF-related conditions. With its favorable physiological changes, the relaxation response is likely to benefit CHF patients.
Key facts
- Study ID
- NCT00012818
- Run by
- US Department of Veterans Affairs
- People needed
- 90
- Expected to finish
- 2003-09-01
- Last updated by the study team
- 2015-04-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- CHF diagnosis, NY stage 2 or 3
Where it is running
- Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA — Bedford, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.